Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Express Scripts
Harvard Business School
Dow
Merck

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PIMOZIDE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Pimozide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004652 ↗ Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome Completed University of Rochester Phase 2 1993-02-01 OBJECTIVES: I. Determine whether the time period between randomization and endpoint is longer in the short term pimozide therapy or longer term therapy in patients with Tourette syndrome. II. Determine whether tic severity, medication side effects, academic performance and psychosocial functioning are better in the short term pimozide therapy or longer term pimozide therapy.
NCT00004652 ↗ Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome Completed National Center for Research Resources (NCRR) Phase 2 1993-02-01 OBJECTIVES: I. Determine whether the time period between randomization and endpoint is longer in the short term pimozide therapy or longer term therapy in patients with Tourette syndrome. II. Determine whether tic severity, medication side effects, academic performance and psychosocial functioning are better in the short term pimozide therapy or longer term pimozide therapy.
NCT00158223 ↗ Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 4 2004-10-01 This study will assess the effectiveness of pimozide in enhancing the effects of clozapine in the treatment of schizophrenia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pimozide

Condition Name

Condition Name for Pimozide
Intervention Trials
Schizophrenia 7
Stress Disorders, Post-Traumatic 2
Psychotic Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Pimozide
Intervention Trials
Schizophrenia 7
Psychotic Disorders 4
Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Pimozide

Trials by Country

Trials by Country for Pimozide
Location Trials
United States 34
Spain 9
Canada 6
United Kingdom 2
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Pimozide
Location Trials
New York 5
California 3
Connecticut 2
North Carolina 2
New Mexico 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Pimozide

Clinical Trial Phase

Clinical Trial Phase for Pimozide
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Pimozide
Clinical Trial Phase Trials
Completed 12
Withdrawn 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Pimozide

Sponsor Name

Sponsor Name for Pimozide
Sponsor Trials
VA Office of Research and Development 2
University of Calgary 2
Stanley Medical Research Institute 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Pimozide
Sponsor Trials
Other 27
U.S. Fed 5
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.